[Quality indicators of type 2-diabetes monitoring during 2000-2005].
BACKGROUND
Considerable attention has been given to the screening and optimization of treatment of people with type 2-diabetes in the period 2000-2005. The aim of this paper is to evaluate the prevalence of people with type 2-diabetes and the quality of diabetes care provided in the period 2000 to 2005.


METHODS
Using a previously evaluated method, all patients with type 2-diabetes were identified and described on the basis of register data in what was then the County of Aarhus.


RESULTS
A total of 11,436 people with type 2-diabetes were identified in the age group 40-70 years, corresponding to a prevalence of 4.61%. In 2005 58% were in antidiabetic pharmacological treatment, 68% of whom received oral antidiabetic treatment, 15% were on insulin alone and 16% received a combination treatment including insulin and oral treatment. Furthermore, a total of 50% of the included patients were on lipid-lowering treatment of whom 99% were in statin-therapy. One or more measurements of HbA1c were taken in 87% of the patients in 2001 compared with 81% in 2005 (p < 0.000). A total of 60% had an HbA1c < 8 in 2001 compared with 67% in 2005 (p < 0.000). In 2001 72% had a cholesterol measurement compared with 77% in 2005 (p < 0.000). A total of 23% had a cholesterol value < 4.5. mmol/l in 2001 compared with 42% in 2005 (p < 0.000).


CONCLUSIONS
During a period of five years the prevalence of people with type 2-diabetes increased. In the same period, improvement was seen in the quality indicators of HbA1c and cholesterol level. There is, however, still room for improvement.
Kristensen
Jette Kolding
JK
Aarhus Universitet, Institut for Folkesundhed, Afdeling for Almen Medicin, DK-8000 Arhus C. jkk@alm.au.dk
Lauritzen
Torsten
T
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D003718:Denmark / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D019984:Quality Indicators, Health Care; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin